drugset
drugset / Trial / NCT05437822

Tranexamic Acid in Proximal Humeral Fractures

NCT05437822 ↗

Phase 4 Unknown 40 enrolled Elda University Hospital Universidad Miguel Hernandez de Elche · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of tranexamic acid (on blood loss and transfusion requirements in patients with proximal humeral fractures requiring open surgical approaches. This a blinded, controlled, therapeutic trial in which the patients will be randomized to receive TXA or no drug intervention. The primary outcome is the estimated total blood loss. This study presents only minimal risks for the included patients.

Timeline

Start
2022-06-29
Primary completion
2023-06-21
Completion
2023-06-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 g Topical

Indications

No indication recorded.